Written By Lisa Murimi
The Pharmacy and Poisons Board (PPB) has issued an urgent recall of Flamodip (Amlodipine) 5 Mg tablets, batch number FLD303, manufactured by Medico Remedies PVT Limited.
The recall, announced on Friday, follows a labelling error that misrepresented the drug’s content.
According to a PPB statement, the secondary packaging of the product is labelled as Flamodip-5 (Amlodipine), while the primary packaging mistakenly identifies the drug as Flamidopril-5 (Enalapril), a medication for different heart conditions.
The board has instructed all pharmaceutical outlets, healthcare facilities, and professionals to halt the sale and distribution of the affected batch immediately.
Members of the public are advised to return any purchased tablets from this batch to the nearest healthcare facility or supplier.
Flamodip (Amlodipine) is prescribed to manage high blood pressure by relaxing blood vessels, reducing the heart’s workload.
However, incorrect use or dosage may lead to severe health issues, including pulmonary edema, a life-threatening condition where the lungs fill with fluid, hampering breathing.
The PPB encourages the public to report any adverse drug reactions or substandard medications through their hotline, USSD code, or online platforms.
Health professionals are also urged to remain vigilant to avoid any mishaps related to the recalled product.
